Article
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
24 Oct 2016
Abstract excerpt
Despite being the most common liver cancer in children, hepatoblastoma (HB) is a rare neoplasm. Consequently, few pretreatment tumors have been molecularly profiled, and there are no validated prognostic or therapeutic biomarkers for HB patients. We report on the first large-scale effort to profile pretreatment HBs at diagnosis. Our analysis of 88 clinically annotated HBs revealed three risk-stratifying molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
